ono 1078 has been researched along with Disease Exacerbation in 3 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "Conventional treatment for acute otitis media mainly targets bacteria with antibiotics, neglecting to control for mediators of inflammation." | 2.82 | The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media. ( Esaki, S; Hamajima, Y; Miyamoto, N; Murakami, S; Nakamura, Y; Nakayama, M; Oshika, M; Sugiyama, K; Suzuki, M; Takagi, I; Yasui, K; Yokota, M, 2016) |
| "Pranlukast attenuates the progression of pulmonary fibrosis in the chronic phase but has no effect on the acute inflammatory response or on the onset of pulmonary fibrosis." | 1.38 | Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice. ( Okunishi, H; Shimbori, C; Shiota, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pike, KC | 1 |
| Akhbari, M | 1 |
| Kneale, D | 1 |
| Harris, KM | 1 |
| Nakamura, Y | 1 |
| Hamajima, Y | 1 |
| Suzuki, M | 1 |
| Esaki, S | 1 |
| Yokota, M | 1 |
| Oshika, M | 1 |
| Takagi, I | 1 |
| Yasui, K | 1 |
| Miyamoto, N | 1 |
| Sugiyama, K | 1 |
| Nakayama, M | 1 |
| Murakami, S | 1 |
| Shimbori, C | 1 |
| Shiota, N | 1 |
| Okunishi, H | 1 |
1 review available for ono 1078 and Disease Exacerbation
| Article | Year |
|---|---|
Interventions for autumn exacerbations of asthma in children.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Behavior The | 2018 |
1 trial available for ono 1078 and Disease Exacerbation
| Article | Year |
|---|---|
The effect of the leukotriene antagonist pranlukast on pediatric acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Child; Child, Preschool; Chromones; Disease Progression; Drug | 2016 |
1 other study available for ono 1078 and Disease Exacerbation
| Article | Year |
|---|---|
Pranlukast, a cysteinyl leukotriene type 1 receptor antagonist, attenuates the progression but not the onset of silica-induced pulmonary fibrosis in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chromones; Cytokines; Disease Progression; Female; Hydroxypro | 2012 |